对于老年妇女的宫颈癌筛查建议进行综述，并确定现行和新兴建议所基于的证据。评估停止老年妇女宫颈癌筛查的可能后果。建议将21-65岁女性的宫颈癌筛查时间间隔加长，并且老年妇女停止筛查。在65岁以上的妇女中，宫颈癌发病和死亡的负担是重大的。老年妇女的人乳头状瘤病毒（HPV）疫苗接种率很低。晚期宫颈癌的发病率在上升，包括腺癌的发病率。阴道癌的发病率也在增加，当妇女不接受常规涂片检查时，妇科护理和检查的频率也会降低。当前的综述表明，基于有限证据建议停止筛查。患者和医生之间存在困惑，以及其他医疗保健人员也存在困惑，不知道该何时对谁进行筛查，这加剧了种族和民族少数人、未投保和农村地区早已知道的医疗保健难度，但癌症的发病率也最快地在白人女性中上升。将筛查时间间隔加长或停止筛查的建议通常是基于认为女性接受检查会带来心理上的痛苦和人口筛查的成本。版权所有 © 2023 Wolters Kluwer Health，Inc. 保留所有权利。

To review the recommendations for cervical cancer screening in older women and to determine the evidence upon which the current and emerging recommendations are based on. To evaluate the possible consequences of stopping cervical cancer screening in older women.Recommendations are to space cervical cancer screening intervals for women aged 21-65 and stop in women older than 65. Cervical cancer incidence and mortality burden are significant in women over the age of 65. Human papillomavirus (HPV) vaccination rates are poor in older women. Advanced cervical cancer rates are increasing, including adenocarcinoma rates. Vulvar carcinoma rates are also increasing, and gynecological care and exams are less frequent when women are not getting routine pap testing.The current review shows that there is limited evidence on which to base the recommendation to stop screening. There is confusion among patients and physicians, and other healthcare providers over who to screen and when, and this is exacerbating the already known difficulty accessing healthcare among racial and ethnic minorities, underinsured, and rural populations, but rates of cancer are also rising most rapidly in white women. Recommendations to space or stop screening are often based on the perceived psychological distress of women undergoing testing and the cost of population screening.Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.